🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Rituximab vs observation after high-dose consolidative first-line chemother...
Status
Terminated
Location
Hôpital Henri Mondor
Start Date
1999-10
Trial ID
NCT00169169
Treatments Being Tested
The purpose of this study is to determine the efficacy and the safety profi...
Status
Completed
Location
Groupe d'Etude des Lymphomes de l'Adulte
Start Date
2006-01-08
Trial ID
NCT00136565
Treatments Being Tested
This study is a multicentric trial evaluating the efficacy of R-ACVBP in pa...
Status
Completed
Location
Groupe d'Etude des Lymphomes de l'adulte
Start Date
2003-12
Trial ID
NCT00144807
Treatments Being Tested
This study is a multicentric randomized trial evaluating the efficacy of th...
Status
Completed
Location
Groupe d'étude des lymphomes de l'adulte
Start Date
2003-12
Trial ID
NCT00140595
Treatments Being Tested
The primary objective of this study is to evaluate the efficacy of doxorubi...
Status
Terminated
Location
Groupe d'Etude des Lymphomes de l'adulte
Start Date
2001-10-16
Trial ID
NCT00135499
This study is designed to investigate: * the interest of a new monoclonal ...
Status
Terminated
Location
ZNA Stuivenberg
Start Date
2012-09
Trial ID
NCT01659099
Treatments Being Tested
The primary objective of the study is to evaluate the efficacy of ASCT as c...
Status
Completed
Location
Service d'Hematologie
Start Date
1999-10
Trial ID
NCT00169130
Treatments Being Tested
Evaluation of the efficacy of a single injection of Pegfilgrastim (6mg) adm...
Status
Completed
Location
Hôpital Henri Mondor
Start Date
2004-05
Trial ID
NCT00169143
Treatments Being Tested
This study is a multicentric randomized trial evaluating the efficacy of th...
Status
Terminated
Location
Groupe d'Etude des Lymphomes de l'adulte
Start Date
2003-12
Trial ID
NCT00140660
Treatments Being Tested
This is a randomized, open-label, multi-center, phase 3 study evaluating th...
Status
Unknown
Location
Ru Feng
Start Date
2017-07-27
Trial ID
NCT03018626